Sign in

CIK 0001653087

  • Accelerated filer
  • Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
822933343
Phone
+1 415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-09-16 Paul Robert Chief Medical Officer Sale −10,000 $19.08 $191K 311,719
2019-08-20 Paul Robert Chief Medical Officer Sale −916 $16.00 $15K 323,719
2019-08-20 Paul Robert Chief Medical Officer Sale −916 $16.00 $15K 321,719
2019-08-19 Paul Robert Chief Medical Officer Sale −1,084 $16.00 $17K 323,719
2019-08-19 King Robert Chief Development Officer Sale −7,500 $15.00 $113K 529,817
2019-08-19 Paul Robert Chief Medical Officer Sale −1,084 $16.00 $17K 322,635
2019-08-15 Paul Robert Chief Medical Officer Sale −10,000 $14.19 $142K 323,719
2019-08-07 ORBIMED ADVISORS LLC 10% owner Sale −492,364 $17.90 $8.8M 9,272,225
2019-08-07 ORBIMED ADVISORS LLC 10% owner Sale −157,636 $17.90 $2.8M 2,968,604

Page 13 of 13 · 249 trades